3-Hydroxybutyric acid-d4 (sodium)

3-Hydroxybutyric acid-d4 (sodium) is the deuterium labeled 3-Hydroxybutyric acid. 3-Hydroxybutyric acid (β-Hydroxybutyric acid) is a metabolite that is elevated in type I diabetes. 3-Hydroxybutyric acid can modulate the properties of membrane lipids[1].

Product Specifications

CAS Number

[1219804-68-8]

Product Name Alternative

β-Hydroxybutyric acid-d4 (sodium)

UNSPSC

12352211

Target

Endogenous Metabolite

Type

Isotope-Labeled Compounds

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Metabolic Disease

Purity

99.74

Solubility

Ethanol : ≥ 5mg/mL|H2O : ≥ 100 mg/mL

Smiles

[2H]C([2H])([2H])C([2H])(O)CC(O[Na])=O

Molecular Formula

C4H3D4NaO3

Molecular Weight

130.11

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Hsu TT, et al. 3-Hydroxybutyric acid interacts with lipid monolayers at concentrations that impair consciousness. Langmuir. 2013 Feb 12;29 (6) :1948-55.